Abstract 288 Table 1
EndpointsCreatinine > 1.5 mg/dL @ 1-Year (n=112)Creatinine > 1.5 mg/dL @ 3-Year (n=31)Creatinine > 1.5 mg/dL @ 5-Year (n=6)P-value
Subsequent 5-Year Survival 74.1% 77.4% 100.0% 0.425
Subsequent 5-Year Freedom from CAV 82.1% 90.3% 100.0% 0.360
Subsequent 5-Year Freedom from NF-MACE 75.9% 74.2% 100.0% 0.427
Subsequent 5-Year Freedom from LV Dysfunction 87.5% 87.1% 100.0% 0.659
Patients on Kidney Dialysis 33.9% 16.1% 0.0% 0.043
Patients with Worsening Kidney Function (development of creatinine > 2.0 mg/dL) 65.2% 61.3% 50.0% 0.715